The ROIC recovery to 9.4% appears driven by a combination of revenue reacceleration (20% year-over-year) and the ~$25M of debt reduction shrinking the invested capital base, rather than a step-change in operating margin, which remains locked in the 5.6%–9.2% band. Against the 10.5% ROE in 2026Q2, the gap between ROE and ROIC narrowed sharply as leverage fell, which means future ROE upside will need to come from margin expansion rather than financial engineering. Compared with peers Kforce (18.4% ROIC) and Huron (15.0%), RCMT still generates returns closer to the staffing cohort's mid-teens-at-best profile than to consulting benchmarks, suggesting the current ROIC trajectory is cyclical recovery rather than a structural re-rating.

Asset turnover has also improved to 0.70 in 2026Q2 from 0.50 in 2024Q3, which explains much of the ROIC recovery independent of margin. However, the simultaneous 54-day compression in DPO over two quarters suggests RCMT is sacrificing supplier float to win terms or capacity, an easing of trade leverage that may not be sustainable if the current growth rate persists. With inventory essentially absent and DIO unreported, the cash conversion cycle is dominated by receivables, meaning any reversal in DSO — for instance, a re-lengthening toward the 100-day norm seen across 2024–2025 — would absorb cash at a rate historically demonstrated by the $13.5M working capital outflow in 2025Q2.

The pace of the paydown — roughly $25M in one quarter — appears to outstrip contemporaneous operating cash flow, suggesting a possible drawdown of a credit facility balance or other balance sheet repositioning whose mechanics warrant confirmation in subsequent filings. At 1.06x net debt-to-EBITDA and 10.68x coverage, refinancing risk is essentially eliminated at current levels, but it also means RCMT has given up the debt capacity that peer Kforce (D/E 0.67) still maintains, potentially constraining M&A optionality. Compared with its own history (D/E of 1.26 in late 2024), the deleveraging is decisive, and with goodwill still representing 45% of equity, the remaining tangible equity cushion is thinner than the headline 0.18x leverage suggests.

The 0.79x EV/Sales multiple looks inexpensive in isolation, but RCMT's 5.2% net margin means the EV/Sales discount versus consulting peers is roughly proportional to its margin gap — the valuation may be accurately pricing a staffing-economics business rather than representing a mispricing. The 14.5x P/FCF is the most flattering metric, though prior cash flow analysis indicates the recent FCF inflection was driven substantially by working capital reversals rather than structural margin gains, so the forward multiple on normalized cash earnings is likely higher than it appears. Investors should note the absent dividend and buyback-heavy capital return profile means the P/E is the primary valuation anchor, and at 15.3x forward earnings the market appears to be pricing RCMT as a mid-teens grower — a rate that the deferred revenue decline to $8.2M from $14.8M may not support.